Cell and gene therapies are hard to make. Raw material limitations, the need for sterility, and industry’s reliance on a limited pool of contractors are among the challenges that are most often cited.
Scientists believe the lymphoid organ-chip should be an asset in the face of a rapidly evolving SARS-CoV-2 pandemic.
Antibiotic resistance could be overcome if phage therapies were produced more efficiently, for example, through the use of recombitrons.
Athira Pharma (ATHA) saw its shares tailspin 81% after its lead candidate fosgonimeton failed the Phase II/III LIFT-AD clinical trial.
Patients with a rare inherited disease affecting their sight experienced quick vision improvements that sustained for a year.
Understanding age-and sex-related differences in melanoma will provide insights that may help lead to the development of personalized therapies.
Scientists believe the lymphoid organ-chip should be an asset in the face of a rapidly evolving SARS-CoV-2 pandemic.
Understanding age-and sex-related differences in melanoma will provide insights that may help lead to the development of personalized therapies.
Athira Pharma (ATHA) saw its shares tailspin 81% after its lead candidate fosgonimeton failed the Phase II/III LIFT-AD clinical trial.
Antibiotic resistance could be overcome if phage therapies were produced more efficiently, for example, through the use of recombitrons.
Patients with a rare inherited disease affecting their sight experienced quick vision improvements that sustained for a year.
